Regeneron Pharmaceuticals Inc.'s victory against Amgen Inc. over anticompetitive drug bundling reinforces the necessity for ...

IIFL Capital has given an Add rating on Gland Pharma with a target price of Rs 1,650. According to the brokerage, Gland ...

Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story PhRMA warns ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Taken together, the reports stand as an indictment of the entire programmatic ecosystem. Critics say the unsuitable ...

Recently, the Trump Administration signed an executive order to lower the prices Americans pay for prescription drugs. It's no secret that brand-name drugs in the U.S. are much more expensive than ...

Interim data from ENERGY 3 trial highlight INZ-701's potential to modify disease course in ENPP1 Deficiency, with sustained ...

U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

The country’s pharma sector is now ranked 3rd in volume and 14th in value globally and contributes as much as 20 per cent of ...